Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jianan Feng, Xiangxue Lu, Han Li & Shixiang Wang. (2022) The roles of hydrogen sulfide in renal physiology and disease states. Renal Failure 44:1, pages 1290-1309.
Read now
Read now
Lei Zhang, Shiqi Zhao, Jinling Ma, Jian Gong, Guizhen Qiu, Yueqin Ren, Ying Zen & Yongbing Shi. (2016) Prevalence and risk factors for pulmonary arterial hypertension in end-stage renal disease patients undergoing continuous ambulatory peritoneal dialysis. Renal Failure 38:5, pages 815-821.
Read now
Read now
Articles from other publishers (45)
Fangyi Hao, Ying Li, Yunzhu Zhang, Yangwenxuan Han, Jing Shang, Lu Gan, Jiaxin Zheng & Chunjian Zhang. (2023) Inhibition of USP1 ameliorates hypertensive nephropathy through regulating oxidative stress and ferroptosis: A precise treatment via SJB3-019A nanodelivery. European Journal of Pharmaceutics and Biopharmaceutics 193, pages 187-197.
Crossref
Crossref
Minyi LiBeifeng LieTingting DuanDeqi ChenTao XiaHeng Xie, Guixuan Lin, Junzheng Yang & Zhenghai Li. (2023) The Protective Effect of Bajijiasu on the Treatment of Hypertensive
Nephropathy in Rats. Current Molecular Pharmacology 16:7.
Crossref
Crossref
Jia-Ming Huan, Xi-Ting Ma, Si-Yi Li, Dong-Qing Hu, Hao-Yu Chen, Yi-Min Wang, Xiao-Yi Su, Wen-Ge Su & Yi-Fei Wang. (2023) Effect of botanical drugs in improving symptoms of hypertensive nephropathy: Analysis of real-world data, retrospective cohort, network, and experimental assessment. Frontiers in Pharmacology 14.
Crossref
Crossref
Siqi Ma, Junyao Xu, Yawei Zheng, Yin Li, Yixuan Wang, Haitao Li, Zhuyuan Fang & Jie Li. (2023) Qian Yang Yu Yin granule improves hypertensive renal damage: A potential role for TRPC6-CaMKKβ-AMPK-mTOR-mediated autophagy. Journal of Ethnopharmacology 302, pages 115878.
Crossref
Crossref
Håvard Mikkelsen, Bjørn E. Vikse, Oystein Eikrem, Andreas Scherer, Kenneth Finne, Tarig Osman & Hans-Peter Marti. (2022) Glomerular proteomic profiling of kidney biopsies with hypertensive nephropathy reveals a signature of disease progression. Hypertension Research 46:1, pages 144-156.
Crossref
Crossref
A. N. Spiridonov, A. D. Khudiakova & E. V. Striukova. (2022) Biochemical and molecular genetic markers of kidney damage in hypertension. "Arterial’naya Gipertenziya" ("Arterial Hypertension") 28:6, pages 614-626.
Crossref
Crossref
ZhongChi Xu, LiChao Qian, RuGe Niu, Ying Yang, ChunLing Liu & Xin Lin. (2022) Efficacy of Huangqi Injection in the Treatment of Hypertensive Nephropathy: A Systematic Review and Meta-Analysis. Frontiers in Medicine 9.
Crossref
Crossref
Xiaoli Yang, Bingqing Zhou, Li Zhou, Liufu Cui, Jing Zeng, Shuo Wang, Weibin Shi, Ye Zhang, Xiaoli Luo, Chunmei Xu, Yuanzheng Xue, Hao Chen, Shuohua Chen, Guodong Wang, Li Guo, Pedro A. Jose, Christopher S. Wilcox, Shouling Wu, Gengze Wu & Chunyu Zeng. (2022) Development and Validation of Prediction Models for Hypertensive Nephropathy, the PANDORA Study. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Üstün YILMAZ, Ayça İNCİ, Ayşe AKARSU & Ümmühan MADEN. (2022) Factors Affecting the Choice of Renal Replacement Therapy in Patients with End Stage Renal Failure. OSMANGAZİ JOURNAL OF MEDICINE.
Crossref
Crossref
Koushu Wang, Duo Qian, Yuncan Hu, Yichun Cheng, Shuwang Ge & Ying Yao. (2022) Nut Consumption and Effects on Chronic Kidney Disease and Mortality in the United States. American Journal of Nephrology 53:6, pages 503-512.
Crossref
Crossref
Preethika Ekanayake & Sunder Mudaliar. (2021) A novel hypothesis linking low‐grade ketonaemia to cardio‐renal benefits with sodium‐glucose cotransporter‐2 inhibitors. Diabetes, Obesity and Metabolism 24:1, pages 3-11.
Crossref
Crossref
Hua-Chun Weng, Xin-Yu Lu, Yu-Peng Xu, Yi-Hong Wang, Dan Wang, Yi-Ling Feng, Zhang Chi, Xiao-Qing Yan, Chao-Sheng Lu & Hong-Wei Wang. (2021) Fibroblast growth factor 21 attenuates salt-sensitive hypertension-induced nephropathy through anti-inflammation and anti-oxidation mechanism. Molecular Medicine 27:1.
Crossref
Crossref
Yanling Song, Zhenbing Bai, Yuanyuan Zhang, Juming Chen, Minghui Chen, Yunbo Zhang, Xiaodian Zhang, Huade Mai, Bingshu Wang, Yunyun Lin & Shenhong Gu. (2021) Protective effects of endothelial progenitor cell microvesicles on Ang II‑induced rat kidney cell injury. Molecular Medicine Reports 25:1.
Crossref
Crossref
Hai-Jian Sun, Zhi-Yuan Wu, Xiao-Wei Nie, Xin-Yu Wang & Jin-Song Bian. (2021) An Updated Insight Into Molecular Mechanism of Hydrogen Sulfide in Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury Under Diabetes. Frontiers in Pharmacology 12.
Crossref
Crossref
Ustun YILMAZ, Selin KIR, Ayca INCI, Nilgun AKSOY, Gulay DEMIRTAS, Semih GUL & Ummuhan MADEN. (2021) ANALYSIS OF SOCIODEMOGRAPHIC CHARACTERISTICS OF EARLY AND ADVANCED STAGE CHRONIC KIDNEY DISEASE PATIENTS. Akdeniz Medical Journal, pages 424-429.
Crossref
Crossref
Jia-Ming Huan, Wen-Ge Su, Wei Li, Chao Gao, Peng Zhou, Chun-Sheng Fu, Xiao-Feng Wang, Yi-Min Wang & Yi-Fei Wang. (2021) Summarizing the Effective Herbs for the Treatment of Hypertensive Nephropathy by Complex Network and Machine Learning. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-12.
Crossref
Crossref
Cody C. GiffordJiaqi TangAngelica CostelloNidah S. KhakooTri Q. Nguyen, Roel Goldschmeding, Paul J. HigginsRohan Samarakoon. (2021) Negative regulators of TGF-β1 signaling in renal fibrosis; pathological mechanisms and novel therapeutic opportunities. Clinical Science 135:2, pages 275-303.
Crossref
Crossref
YiZhuo Li, Shihai Yan, Lichao Qian, Lihua Wu, Yawei Zheng & Zhuyuan Fang. (2020) Danhong Injection for the Treatment of Hypertensive Nephropathy: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 11.
Crossref
Crossref
Yi Shan Huang, Xu Wang, Zhendong Feng, Hailan Cui, Zebing Zhu, Chenhui Xia, Xueting Han, Wei Jing Liu & Yu Ning Liu. (2020)
Cordyceps cicadae
Prevents Renal Tubular Epithelial Cell Apoptosis by Regulating the SIRT1/p53 Pathway in Hypertensive Renal Injury
. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-13.
Crossref
Crossref
Xiaobing Ji. 2020. Chronic Kidney Disease. Chronic Kidney Disease
45
56
.
Junyao Xu, Chenghua Zhang, Xiaoqing Shi, Jie Li, Ming Liu, Weimin Jiang & Zhuyuan Fang. (2019) Efficacy and Safety of Sodium Tanshinone IIA Sulfonate Injection on Hypertensive Nephropathy: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 10.
Crossref
Crossref
Junjie Cao, Rui Hou, Jingqian Lu, Kongyan Zhang, Cui Zhao, Haisen Jiang, Yumei Feng & Yiwei Wang. (2019) The predictive value of β2‑MG and TGF‑β for elderly hypertensive nephropathy. Experimental and Therapeutic Medicine.
Crossref
Crossref
Alp Tuna Beksac, Balaji N Reddy, Alberto Martini, David J Paulucci, Erin Moshier, Ronney Abaza, Daniel D Eun, Ashok K Hemal & Ketan K Badani. (2019) Hypertension and diabetes mellitus are not associated with worse renal functional outcome after partial nephrectomy in patients with normal baseline kidney function. International Journal of Urology 26:1, pages 120-125.
Crossref
Crossref
Mariam L. Alam, Ronit Katz, Keith A. Bellovich, Zeenat Y. Bhat, Frank C. Brosius, Ian H. de Boer, Crystal A. Gadegbeku, Debbie S. Gipson, Jennifer J. Hawkins, Jonathan Himmelfarb, Bryan R. Kestenbaum, Matthias Kretzler, Cassianne Robinson-Cohen, Susan P. Steigerwalt, Courtney Tuegel & Nisha Bansal. (2019) Soluble ST2 and Galectin-3 and Progression of CKD. Kidney International Reports 4:1, pages 103-111.
Crossref
Crossref
Claudio Ronco, Luca Di Lullo & Peter A. McCullough. 2019. Critical Care Nephrology. Critical Care Nephrology
677
689.e2
.
Peter A. McCullough & Claudio Ronco. 2019. Critical Care Nephrology. Critical Care Nephrology
664
670.e3
.
Hai-Jian Sun. 2019. Renal Fibrosis: Mechanisms and Therapies. Renal Fibrosis: Mechanisms and Therapies
37
47
.
Stancho S. Stanchev, Alexandar A. Iliev, Lina G. Malinova, Boycho V. Landzhov, Georgi N. Kotov & Dimka V. Hinova-Palova. (2017) Light Microscopic Study of Renal Morphological Alterations in Spontaneously Hypertensive Rats. Journal of Biomedical and Clinical Research 10:1, pages 18-24.
Crossref
Crossref
Davide Bolignano & Carmine Zoccali. (2017) Non-proteinuric rather than proteinuric renal diseases are the leading cause of end-stage kidney disease. Nephrology Dialysis Transplantation 32:suppl_2, pages ii194-ii199.
Crossref
Crossref
Jiayi Gu, Jianqian Chao, Wenji Chen, Hui Xu, Zhenchun Wu, Huanghui Chen, Tingting He, Lin Deng & Ruizhi Zhang. (2017) Multimorbidity in the community-dwelling elderly in urban China. Archives of Gerontology and Geriatrics 68, pages 62-67.
Crossref
Crossref
Wolfgang KrügerWolfgang Krüger. 2017. Acute Heart Failure. Acute Heart Failure
371
401
.
Zhi Chen, Hao Wu, Guohua Wang & Ye Feng. (2016) Identification of potential candidate genes for hypertensive nephropathy based on gene expression profile. BMC Nephrology 17:1.
Crossref
Crossref
Xu Cao & Jin-Song Bian. (2016) The Role of Hydrogen Sulfide in Renal System. Frontiers in Pharmacology 7.
Crossref
Crossref
Mengying Zhou, Xulang Zhang, Xinyu Wen, Taihua Wu, Weidong Wang, Mingzhou Yang, Jing Wang, Ming Fang, Bingcheng Lin & Hongli Lin. (2016) Development of a Functional Glomerulus at the Organ Level on a Chip to Mimic Hypertensive Nephropathy. Scientific Reports 6:1.
Crossref
Crossref
Y. Zeng, D.D. Yang, S. Feng, H.Y. Shen, Z. Wang, S. Jiang, Y.B. Shi & J.X. Fu. (2016) Risk factors for pulmonary hypertension in patients receiving maintenance peritoneal dialysis. Brazilian Journal of Medical and Biological Research 49:3.
Crossref
Crossref
Michelle J. Pena, Joachim Jankowski, Georg Heinze, Maria Kohl, Andreas Heinzel, Stephan J.L. Bakker, Ron T. Gansevoort, Peter Rossing, Dick de Zeeuw, Hiddo J. Lambers Heerspink & Vera Jankowski. (2015) Plasma proteomics classifiers improve risk prediction for renal disease in patients with hypertension or type 2 diabetes. Journal of Hypertension 33:10, pages 2123-2132.
Crossref
Crossref
Soham Rej, Dominique Elie, Istvan Mucsi, Karl J. Looper & Marilyn Segal. (2014) Chronic Kidney Disease in Lithium-Treated Older Adults: A Review of Epidemiology, Mechanisms, and Implications for the Treatment of Late-Life Mood Disorders. Drugs & Aging 32:1, pages 31-42.
Crossref
Crossref
Bo-hyun Choi, Kyung-Shin Kang & Mi-Kyoung Kwak. (2014) Effect of Redox Modulating NRF2 Activators on Chronic Kidney Disease. Molecules 19:8, pages 12727-12759.
Crossref
Crossref
Ovidiu C. Baltatu, Christian E. Zaugg, Christoph Schumacher, Pat Louie, Luciana A. Campos & Michael Bader. (2014) Avosentan is protective in hypertensive nephropathy at doses not causing fluid retention. Pharmacological Research 80, pages 9-13.
Crossref
Crossref
P. B. L. Hansen. (2013) Functional and pharmacological consequences of the distribution of voltage‐gated calcium channels inthe renal blood vessels. Acta Physiologica 207:4, pages 690-699.
Crossref
Crossref
Merel E. Hellemons, Hiddo J. Lambers Heerspink, Ron T. Gansevoort, Dick de Zeeuw & Stephan J.L. Bakker. (2013) High-sensitivity troponin T predicts worsening of albuminuria in hypertension; results of a nested case–control study with confirmation in diabetes. Journal of Hypertension 31:4, pages 805-812.
Crossref
Crossref
Guan-Xian Liu, You-Qi Li, Xiao R. Huang, Lihua Wei, Hai-Yong Chen, Yong-Jun Shi, Rainer L. Heuchel & Hui Y. Lan. (2013) Disruption of Smad7 Promotes ANG II-Mediated Renal Inflammation and Fibrosis via Sp1-TGF-β/Smad3-NF.κB-Dependent Mechanisms in Mice. PLoS ONE 8:1, pages e53573.
Crossref
Crossref
Claudio Ronco, Mariantonietta Cicoira & Peter A. McCullough. (2012) Cardiorenal Syndrome Type 1. Journal of the American College of Cardiology 60:12, pages 1031-1042.
Crossref
Crossref
Zhen Liu, Xiao R. Huang & Hui Y. Lan. (2012) Smad3 mediates ANG II-induced hypertensive kidney disease in mice. American Journal of Physiology-Renal Physiology 302:8, pages F986-F997.
Crossref
Crossref
. (2011) Current World Literature. Current Opinion in Nephrology & Hypertension 20:5, pages 561-571.
Crossref
Crossref